The “severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” is the third member of
human coronavirus (CoV) that is held accountable for the current “coronavirus disease 2019 …

Today, viruses penetrate cells very intelligently with abilities of replicating and disabling the
host's defense mechanisms. The viruses are resistant to conventional treatments mainly due …

Favipiravir is one of the most commonly prescribed drugs in the treatment of COVID-19 in
the early stages of the disease. In this work, the solubility of favipiravir was measured in …

Nanotechnology has gained immense attention owing to its multidimensional advantages in
the scientific world. Recent progress has confirmed that nanostructured architectures …

In 2019 the emergence of SARS-COV-2 caused pandemic situation worldwide and
claimed∼ 6.4 M lives (WHO 2022). Favipiravir (FAV) is recommended as a therapy for Covid …

In this paper, a theoretical investigation is made regarding the possibility of using a water-
soluble derivative of C60 as a drug delivery agent for treating Coronavirus disease 2019 …

Favipiravir (FVR) is a repurposed antiviral drug for treating mild to moderate cases of the
novel coronavirus disease 2019 (COVID-19). However, its poor solubility and permeability …

The adsorption behavior of antiviral drug Favipiravir (FPV) on B n N n (n= 12, 16, 20, and 24)
surface has been systemically investigated by analyzing the geometric, electronic, and …

Following the announcement of the outbreak of COVID-19 by the World Health Organization,
unprecedented efforts were made by researchers around the world to combat the disease …

Atherosclerosis-induced coronary artery disease is a major cause of cardiovascular
mortality. Clinically, conservative treatment strategies for atherosclerosis still focus on …